Drug minimization in transplantation: An opinion

Current Opinion in Organ Transplantation

Volumn 19, Issue 4, 2014, Pages 331-333

  Waldmann, Herman ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL THERAPY; COMPLEMENT ACTIVATION; DENDRITIC CELL; DRUG USE; LYMPHOCYTE DEPLETION; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 84940234162     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000099     Document Type: Review

References (7)

1. Sachs DH, Kawai T, Sykes M. Induction of tolerance through mixed chimerism. Cold Spring Harb Perspect Med 2014; 4:a015529.
2. Or-Geva N, Reisner Y. Megadose stem cell administration as a route to mixed chimerism. Curr Opin Organ Transplant 2014; 19:334-341.
3. Asgari E, Farrar CA, Sacks SH. Control of innate immunological mechanisms as a route to drug minimization. Curr Opin Organ Transplant 2014; 19:342-347.
4. Morelli AE, Thomson AW. Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells. Curr Opin Organ Transplant 2014; 19:348-356.
5. Zwang NA, Turka LA. Homeostatic expansion as a barrier to lymphocyte depletion strategies. Curr Opin Organ Transplant 2014; 19:357-362.
6. Waldmann H, Hilbrands R, Howie D, Cobbold S. Harnessing FOXP3R regulatory T cells for transplantation tolerance. J Clin Invest 2014; 124:1439-1445.
7. Lo Y-C, Lee C-F, Powell JD. Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant 2014; 19:363-371.